Dr. Kate Wolfer

Kate joined the Zamboni lab in May 2023, with a wide range of prior experiences in small molecule mass spectrometry and statistical approaches. Her PhD focused on holistic untargeted metabolite and lipid profiling of an animal model of obesity. Since then, she has held postdoctoral positions in biostatistics and bioinformatics, and additionally as field service engineer for Waters and field application scientist at Bruker.

Her main interests lie in clinical and pharmaceutical applications of metabolomics, multiomics studies, instrument and method development, and “big data” statistical analyses, integration and visualization. She is currently working on novel approaches in tandem mass spectrometric data acquisition and data analysis, and is responsible for clinical studies within the SMOC and Swiss PHRT remits.

Education

• PhD in metabolomics at Imperial College London, supervised by Professors Ian Wilson and Jeremy Nicholson
• Master in Chemistry with Study in Europe at Newcastle University (UK)

Selected Publications

• external page Atmospheric conditions and composition that influence PM_2.5 oxidative potential in Beijing, China
• external page Characterization and Quantification of Particle-Bound Criegee Intermediates in Secondary Organic
• external page Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte Activation